Synergistic association between underweight and type 2 diabetes on the development of laryngeal cancer: a national population-based retrospective cohort study

[1]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[2]  Yongbo Wang,et al.  Type 2 diabetes mellitus and risk of head and neck cancer subtypes: a systematic review and meta-analysis of observational studies , 2021, Acta Diabetologica.

[3]  Hun‐Sung Kim,et al.  Diabetes Fact Sheets in Korea, 2020: An Appraisal of Current Status , 2021, Diabetes & metabolism journal.

[4]  H. Morgenstern,et al.  Alcohol drinking and head and neck cancer risk: the joint effect of intensity and duration , 2020, British Journal of Cancer.

[5]  E. Lee,et al.  Prediction of Cancer Incidence and Mortality in Korea, 2020 , 2020, Cancer research and treatment : official journal of Korean Cancer Association.

[6]  Z. Dai,et al.  Global burden of larynx cancer, 1990-2017: estimates from the global burden of disease 2017 study , 2020, Aging.

[7]  P. Ramos-García,et al.  Diabetes Mellitus and oral cancer/oral potentially malignant disorders: a systematic review and meta-analysis. , 2020, Oral diseases.

[8]  S. Suh,et al.  Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment , 2019, Diabetes & metabolism journal.

[9]  J. Kim,et al.  Relationship between the discomfort with mastication and the average daily sleeping time in korean general women: analysis based on the 2016 korea national health and nutrition examination survey (KNHANES) , 2019 .

[10]  Hongbing Shen,et al.  Body mass index and the risk of head and neck cancer in the Chinese population. , 2019, Cancer epidemiology.

[11]  J. S. Kim,et al.  Dose–response relationship between cigarette smoking and risk of ulcerative colitis: a nationwide population-based study , 2019, Journal of Gastroenterology.

[12]  C. Mantzoros,et al.  Obesity and cancer risk: Emerging biological mechanisms and perspectives. , 2019, Metabolism: clinical and experimental.

[13]  M. Tsai,et al.  Incidence and relative risk for developing cancers in women with gestational diabetes mellitus: a nationwide cohort study in Taiwan , 2019, BMJ Open.

[14]  Kyungdo Han,et al.  Metabolic Syndrome and Incidence of Laryngeal Cancer: A Nationwide Cohort Study , 2019, Scientific Reports.

[15]  D. Conway,et al.  The changing epidemiology of oral cancer: definitions, trends, and risk factors , 2018, BDJ.

[16]  Kyungdo Han,et al.  Site-specific cancer risk in patients with type 2 diabetes: a nationwide population-based cohort study in Korea , 2018, The Korean journal of internal medicine.

[17]  Ki-Up Lee,et al.  Past and Current Status of Adult Type 2 Diabetes Mellitus Management in Korea: A National Health Insurance Service Database Analysis , 2018, Diabetes & metabolism journal.

[18]  Publisher's Note , 2018, Anaesthesia.

[19]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[20]  S. Khariwala,et al.  Tobacco-related carcinogenesis in head and neck cancer , 2017, Cancer and Metastasis Reviews.

[21]  Umber Saeed,et al.  Innovative approaches in metabolomics for understanding drug resistance in breast cancer , 2017 .

[22]  D. Leroith,et al.  Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Jun Wang,et al.  Associations of body mass index with cancer incidence among populations, genders, and menopausal status: A systematic review and meta-analysis. , 2016, Cancer epidemiology.

[24]  M. Bolanowski,et al.  Diabetes and Cancer: a Review of Current Knowledge. , 2016, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[25]  Malay Kumar,et al.  Oral cancer: Etiology and risk factors: A review. , 2016, Journal of cancer research and therapeutics.

[26]  L. Schouten,et al.  Body mass index and risk of subtypes of head-neck cancer: the Netherlands Cohort Study , 2015, Scientific Reports.

[27]  L. Smeeth,et al.  The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement , 2015, PLoS medicine.

[28]  Derek LeRoith,et al.  Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality. , 2015, Physiological reviews.

[29]  J. Ioannidis,et al.  Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies , 2015, BMJ : British Medical Journal.

[30]  K. Bhaskaran,et al.  Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults , 2014, The Lancet.

[31]  D. Luce,et al.  Body mass index, body mass change, and risk of oral cavity cancer: results of a large population-based case–control study, the ICARE study , 2013, Cancer Causes & Control.

[32]  G. Fountzilas,et al.  Insulin-Like Growth Factor 1 Receptor (IGF1R) Expression and Survival in Operable Squamous-Cell Laryngeal Cancer , 2013, PloS one.

[33]  D. Giugliano,et al.  Metabolic Syndrome and Risk of Cancer , 2012, Diabetes Care.

[34]  K. McGlynn,et al.  Risk of cancer in a large cohort of U.S. veterans with diabetes , 2011, International journal of cancer.

[35]  K. Straif,et al.  Alcohol drinking and laryngeal cancer: overall and dose-risk relation--a systematic review and meta-analysis. , 2010, Oral oncology.

[36]  H. Morgenstern,et al.  Body mass index, cigarette smoking, and alcohol consumption and cancers of the oral cavity, pharynx, and larynx: modeling odds ratios in pooled case-control data. , 2010, American journal of epidemiology.

[37]  M. Toner,et al.  Head and Neck Squamous Cell Carcinoma in the Young: A Spectrum or a Distinct Group? Part 2 , 2009, Head and neck pathology.

[38]  B. P..  The lean patient with type 2 diabetes: characteristics and therapy challenge , 2007, International journal of clinical practice. Supplement.

[39]  Piotr Rapiejko,et al.  [Laryngeal cancer risk factors]. , 2006, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.

[40]  P. Roderick,et al.  Estimating kidney function in adults using formulae , 2005, Annals of clinical biochemistry.

[41]  D. McNeeley,et al.  Mechanisms of nutrient modulation of the immune response. , 2005, The Journal of allergy and clinical immunology.

[42]  Emiel F M Wouters,et al.  Body mass index modulates aromatic DNA adduct levels and their persistence in smokers. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[43]  C. la Vecchia,et al.  Leanness as early marker of cancer of the oral cavity and pharynx. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[44]  P. Boyle,et al.  Epidemiology of laryngeal cancer. , 1996, European journal of cancer. Part B, Oral oncology.

[45]  K. Higgins,et al.  An update on larynx cancer , 2017, CA: a cancer journal for clinicians.